MAP1LC3A and Alzheimer disease: Subsequently, it was shown that AVs in brain tissue and protein markers of AVs such as MAP1LC3/LC3 (microtubule associated protein 1 light chain 3)-II increase with increasing AD progression/severity, being higher in later Braak stage than in early Braak stage AD patients and normal controls [19].